Each newer medication activates additional hormone receptors that influence how the body regulates weight and energy. *Retatrutide is currently in Phase 3 of approval* The more receptors involved doesn't automatically mean a medication is "better." It simply means it works through additional biological pathways that may be beneficial for certain patients
One morning youre standing in front of your fridge at 6 AM, pen in hand, ready for your weekly GLP-1 injection
However, semaglutide: Does not activate GIP receptors There is less evidence supporting antifibrotic or thermogenic effects May offer some symptomatic relief in cases with concurrent obesity, but not necessarily address lipedemas root pathology
For references and more information , see the section on hypertension in the Calcium article
Some combinations work beautifully
Real clinical results live in trial reports, not on a hero image